Stock comparison
Abbott Laboratories
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ABT
Abbott Laboratories
Market cap
$152.25B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ABT | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 61C | 69B | MTD |
| Benjamin Graham | 69B | 65B | ABT |
| Philip Fisher | 46D | 63C | MTD |
| Peter Lynch | 24F | 66B | MTD |
| Joel Greenblatt | 42D | 68B | MTD |
| Charlie Munger | 57C | 74B | MTD |
| Terry Smith | 54D | 70B | MTD |
Side-by-side metrics
| Metric | ABT | MTD |
|---|---|---|
| Market cap | $152.25B | $22.29B |
| P/E (TTM) | 23.5x | 25.3x |
| EV/EBIT | 21.7x | 21.6x |
| ROIC (TTM) | 6.56% | 36.09% |
| Gross margin | 56.38% | 57.79% |
| Net margin | 13.91% | 21.4% |
| Revenue CAGR 5y | 0.72% | 2.01% |
| EPS CAGR 5y | -1.48% | 6.12% |
| Debt / Equity | 0.7x | - |
| Dividend yield | 2.89% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ABT leads on
- Dividend yield2.89%vs 0.0%+100%
- Market cap$152.25Bvs $22.29B+85%
- P/E (TTM)23.5xvs 25.3x+7%
MTD leads on
- EPS CAGR 5y6.12%vs -1.48%+124%
- Debt / Equity-vs 0.7x+101%
- ROIC (TTM)36.09%vs 6.56%+82%
- Revenue CAGR 5y2.01%vs 0.72%+64%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.